Search

Florida Preferred Care Network Special Needs Plans

Preferred Care Network Medicare Advantage Special Needs Plans (SNPs) are HMO plans in Miami-Dade and Broward counties. These plans combine the hospital and doctor coverage of Medicare Parts A and B with Part D prescription drug coverage, plus additional benefits and services designed to meet the unique needs of identified Medicare consumer populations.

The Preferred Care Network Dual Eligible SNP plans is intended for consumers eligible for Medicare & Medicaid benefits. This plan requires referrals for specialty care.

  • UHC MedicareMax Medicare Advantage (HMO D-SNP)

The Preferred Care Network Chronic Condition SNP plan provides specialized benefits and services for Medicare beneficiaries with chronic conditions such as diabetes, heart failure and/or cardiovascular disorders. This plan requires referrals for specialty care.

  • UHC MedicareMax Complete Care (HMO C-SNP)

Health Maintenance Organization (HMO) plans have a defined network of contracted local physicians and hospitals to provide member care. Generally, members must use these care providers to receive benefits for covered services, except in emergencies.

Plans are insured through UnitedHealthcare Insurance Company or one of its affiliated companies, a Medicare Advantage organization with a Medicare contract and a contract with the State Medicaid Program. Enrollment in the plan depends on the plan’s contract renewal with Medicare. This plan is available to anyone who has both Medical Assistance from the State and Medicare. 

Additional Coverage Information

Coverage options may vary depending upon your location. To learn more about a plan in your service area, go to PCNHealth.com.

Medicare Part D Information

To learn more about Medicare Part D prescription drug coverage or to access related forms, please review the Prescription Drug Resources materials available on PCNHealth.com. This section contains information and forms for direct member reimbursement, medication prior authorization, and the prescription drug transition process.